These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15368379)

  • 1. Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics strategy.
    LaPlante SR; Jakalian A; Aubry N; Bousquet Y; Ferland JM; Gillard J; Lefebvre S; Poirier M; Tsantrizos YS; Kukolj G; Beaulieu PL
    Angew Chem Int Ed Engl; 2004 Aug; 43(33):4306-11. PubMed ID: 15368379
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
    Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
    Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency.
    Beaulieu PL; Bös M; Bousquet Y; DeRoy P; Fazal G; Gauthier J; Gillard J; Goulet S; McKercher G; Poupart MA; Valois S; Kukolj G
    Bioorg Med Chem Lett; 2004 Feb; 14(4):967-71. PubMed ID: 15013003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
    McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
    Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole.
    Ishida T; Suzuki T; Hirashima S; Mizutani K; Yoshida A; Ando I; Ikeda S; Adachi T; Hashimoto H
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1859-63. PubMed ID: 16455252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.
    Beaulieu PL; Gillard J; Bykowski D; Brochu C; Dansereau N; Duceppe JS; Haché B; Jakalian A; Lagacé L; LaPlante S; McKercher G; Moreau E; Perreault S; Stammers T; Thauvette L; Warrington J; Kukolj G
    Bioorg Med Chem Lett; 2006 Oct; 16(19):4987-93. PubMed ID: 16908138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.
    Chan L; Reddy TJ; Proulx M; Das SK; Pereira O; Wang W; Siddiqui A; Yannopoulos CG; Poisson C; Turcotte N; Drouin A; Alaoui-Ismaili MH; Bethell R; Hamel M; L'Heureux L; Bilimoria D; Nguyen-Ba N
    J Med Chem; 2003 Apr; 46(8):1283-5. PubMed ID: 12672227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-hydrolysable analogs of inorganic pyrophosphate as inhibitors of hepatitis C virus RNA-dependent RNA-polymerase].
    Ianvarev DV; Korovina AN; Usanov NN; Kochetkov SN
    Bioorg Khim; 2012; 38(2):257-62. PubMed ID: 22792731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of finger loop inhibitors of the hepatitis C virus NS5B polymerase: status and prospects for novel HCV therapeutics.
    Beaulieu PL
    IDrugs; 2006 Jan; 9(1):39-43. PubMed ID: 16374732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Tomei L; Altamura S; Bartholomew L; Biroccio A; Ceccacci A; Pacini L; Narjes F; Gennari N; Bisbocci M; Incitti I; Orsatti L; Harper S; Stansfield I; Rowley M; De Francesco R; Migliaccio G
    J Virol; 2003 Dec; 77(24):13225-31. PubMed ID: 14645579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
    Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Koch U; Narjes F
    Curr Top Med Chem; 2007; 7(13):1302-29. PubMed ID: 17627559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in silico NS5B polymerase inhibitory activity of benzimidazole derivatives.
    Patil VM; R GK; Chudayeu M; Gupta SP; Samanta S; Masand N; Kaushik-Basu N
    Med Chem; 2012 Jul; 8(4):629-35. PubMed ID: 22530910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Resistance of Hepatitis C Virus NS5B Polymerase Inhibitors via Docking and Molecular Dynamics Simulation.
    Uengwetwanit T; Robaa D; Sippl W
    Mol Inform; 2015 Feb; 34(2-3):78-83. PubMed ID: 27490030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase.
    Deng Y; Shipps GW; Wang T; Popovici-Muller J; Rosner KE; Siddiqui MA; Duca J; Cooper AB; Cable M
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5363-7. PubMed ID: 19682898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.
    Chan L; Pereira O; Reddy TJ; Das SK; Poisson C; Courchesne M; Proulx M; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Roy C; Nasturica D; Moinet C; Bethell R; Hamel M; L'Heureux L; David M; Nicolas O; Courtemanche-Asselin P; Brunette S; Bilimoria D; Bédard J
    Bioorg Med Chem Lett; 2004 Feb; 14(3):797-800. PubMed ID: 14741292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Lai VC; Zhong W; Wu JZ
    Bioorg Med Chem Lett; 2005 Feb; 15(3):675-8. PubMed ID: 15664835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase.
    Donner PL; Xie Q; Pratt JK; Maring CJ; Kati W; Jiang W; Liu Y; Koev G; Masse S; Montgomery D; Molla A; Kempf DJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2735-8. PubMed ID: 18362072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.